News & Events

• July 28, 2015
  

  Correlations Between the Hollow Fiber Model of Tuberculosis and Therapeutic Events in Tuberculosis Patients: Learn and Confirm

  Gumbo T, Pasipanodya JG, Nuermberger E, Romero K, Hanna D. Correlations Between the Hollow Fiber Model of Tuberculosis and Therapeutic Events in Tuberculosis Patients: Learn and Confirm. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2015 Jul 28;61 Suppl 1:S18–24.

• July 27, 2015
  

  FDA: Guidance for Industry Duchenne Muscular Dystrophy Developing Drugs for Treatment Over the Spectrum of Disease

• July 14, 2015
  

  The Predictive Safety Testing Consortium: Safety Biomarkers, Collaboration, and Qualification

  Sauer JM, Walker EG, Porter AC. The Predictive Safety Testing Consortium: Safety Biomarkers, Collaboration, and Qualification. Journal of Medicines Development Sciences. 2015 Jul 14;1(1).

• June 26, 2015
  

  Patient-Centered Research To Support The Development Of The Symptoms Of Major Depressive Disorder Scale (SMDDS): Initial Qualitative Research

• June 15, 2015
  

  Assessing the Landscape of Tools and Approaches for Novel Tuberculosis Regimen Development

  Nuermberger E, Hanna D. Assessing the Landscape of Tools and Approaches for Novel Tuberculosis Regimen Development. The Journal of Infectious Diseases. 2015 Jun 15;211 Suppl 3:S81–2.